<DOC>
	<DOCNO>NCT00629096</DOCNO>
	<brief_summary>The main aim study determine whether intracoronary infusion autologous bone marrow mononuclear cell improve ventricular function patient idiopathic dilate cardiomyopathy.Secondary end-points : 1 . To evaluate possible change patient functional capacity 2. identify biological characteristic bone marrow graft might influence functional recovery .</brief_summary>
	<brief_title>Intracoronary Infusion Autologous Bone Marrow Cells Treatment Idiopathic Dilated Cardiomyopathy</brief_title>
	<detailed_description>Clinical study show bone marrow cell regenerate damage myocardium ischemic cardiopathy ; however scarce information available patient non-ischemic dilated cardiomyopathy . The aim present work investigate role intracoronary infusion autologous marrow-derived stem cell phase II study 30 patient dilate cardiomyopathy.Before intracoronary transplant marrow cell well six twelve month thereafter , compare ventricular function measure left-ventricular ejection fraction angiography , magnetic resonance imaging , echocardiography treadmill direct oxygen consumption test . Functional capacity monitor throughout study . In every condition study perform least one 30º right anterior oblique leave ventricle ( LV ) angiogram . During ventriculogram , attempt make obtain sinus post-extrasystolic beat analysis , order study contractile reserve behaviour . Post-extrasystolic beat obtain induce premature beat catheter , well opacified cardiac cycle normal sinus beat film . In instance , r-r ' interval induce premature beat post-extrasystolic pause record measure . Measurements calculation make line core lab , end-diastolic end-systolic silhouette draw use CASS system 2 expert angiographers unaware patient group study condition . LV-volumes ejection fraction ( EF ) derive regional wall motion analyze . The method Sheehan ( 1 ) use asynergy study , divide superimpose silhouette 100 radius wall shortening , end-diastole end-systole . The abnormal contracting segment ( ACS ) define percentage radius show akinesia dyskinesia . The area ventrivular wall asynergy regionally evaluate . The serial evolution contractile reserve evaluate post-extrasystolic potentiation . Coronary Flow Reserve ( CFR ) 3 coronary artery also evaluate every hemodynamic study ( treatment 6 month treatment ) . The FloMap® system ( Cardiometrics ; Mountain View ; California ) use . A 0.014 '' intracoronary Doppler guide wire position proximally every coronary flow velocity record continuously . Average peak velocity obtain baseline intracoronary bolus Adenosine . CFR calculate ratio maximal flow velocity peak effect adenosine injection basal flow velocity . Magnetic Resonance Image ( MRI ) study perform 3 condition ( baseline , 3-month 1-year treatment ) . Functional parameter obtain condition , include LV-volumes , LV-mass ejection fraction On morning cardiac catheterization , volume 100-150 ml marrow obtain local anesthesia aspiration iliac crest . Mononuclear Bone Marrow Cells ( MNBMCs ) isolate density gradient centrifugation Ficoll-Hypaque technique sterile , semiautomated device COBE® 2991 . After three wash , MNBMCs filter resuspend 10 ml 0.9 % sodium chloride supplement preservative-free 0.1 % heparin . Aliquots obtain cell count well cytofluorometric functional analysis cell content . Cells directly transfer 3 coronary artery ( 50 % leave anterior descend artery , 25 % circumflex 25 % right coronary artery ) use coaxial balloon catheter , place proximally artery . Balloon size select accord vessel size , order achieve complete occlusion vessel stop flow cell injection . So , backflow cell prevent distal stagnant flow facilitate cell exposure . The cell suspension inject distal tip balloon 2 4 minute . In addition , try compare possible change functional parameter biological variable obtain marrow graft , : 1 . Number cell positive cluster differentiation antigen ( CD ) CD146 , CD31 , CD133 , CD90 , CD38 , CD117 , CD73 , CD105 , CD45 , Vascular endothelial growth factor receptor 2 , CXC-chemokine receptor 4 HLA-DR. 2 . Functional characterization endothelial progenitor cell mesenchymal stem cell present graft vitro selective culture . 3 . Analysis vitro chemotactic ability infuse cell . 4 . Determination lineage-specific cardiac marker GATA-4 Nk2.5/Csx infuse marrow-derived cell . Correlations biological parameter effect patient ` ventricular function could highlight role potential mechanism imply cell-mediated myocardial regeneration .</detailed_description>
	<mesh_term>Cardiomyopathies</mesh_term>
	<mesh_term>Cardiomyopathy , Dilated</mesh_term>
	<criteria>1 . Patients gender establish clinical angiographic diagnosis Idiopathic Dilated Cardiomyopathy accept participate trial . 2 . They symptoms and/or sign heart failure , despite optimized medical treatment . 3 . Angiographic ejection fraction le 50 % . 1 . Associated coronary artery disease . 2 . Any history suspicion toxic , pharmacologic deposit etiology . 3 . Absence resynchronization therapy . 4 . Age longer 80 year . 5 . Associated malignant premalignant systemic disease . 6 . Associated hematologic disorder .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>May 2013</verification_date>
	<keyword>Dilated Cardiomyopathy</keyword>
	<keyword>Marrow stem cell</keyword>
	<keyword>Myocardial regeneration</keyword>
	<keyword>Mesenchymal stem cell</keyword>
	<keyword>Marrow-derived endothelial progenitor cell</keyword>
</DOC>